Skip to main content

Table 1 Results of a systematic review on hepatitis C virus prevalence in incarcerated settings

From: Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis

 

Author

Publication year

Sample size

Enrolment dates

Prevalence HCV (%)

Ab

RNA

Eastern Europe

 Azerbaijan

Azbel L et al. [23]

2015

510

2014

38.2

-

 Bosnia and Herzegovina

Hodzic H et al. [24]

2017

200

2013

13.0

-

 Estonia

Kivimets K et al. [25]

2018

1,845

2014–2015

-

56.3

 Georgia

Bergen-Cico D et al. [26]

2017

500

2016

60.0

-

Harris AM et al. [27]

2019

13,500

2013–2015

38.0

28.4

 Hungary

Vanya M et al. [28]

2017

200

2014

1.0

-

 Macedonia

Jovanovska T et al. [29]

2014

200

-

20.0

-

 Turkey

Keten D et al. [30]

2016

266

2014–2015

17.7

8.6

Kose S et al. [31]

2019

360

-

0.5

-

 Ukraine

Azbel L et al. [32]

2013

402

2011

60.2

-

Western Europe

 Austria

Silbernagl M et al. [33]

2018

133

-

74.4

45.0

 Belgium

Busschots D et al. [34]

2021

886

2019–2020

5.0

2.1

 Denmark

Soholm J et al. [35]

2019

801

2016–2017

7.4

4.2

 France

Semaille C et al. [36]

2013

2,154

2010

4.8

2.5

Roux P et al. [37]

2014

5,957

2004–2010

5.2

-

Jacomet C et al. [38]

2016

342

2012–2013

4.7

1.5

Izquierdo L et al. [39]

2019

1,093

2017

2.9

1.1

 Ireland

Crowley D et al. [40]

2019

422

2017

22.8

5.5

 Italy

Brandolini M et al. [41]

2013

695

2006–2008

22.4

19.4

Foschi A et al. [42]

2016

3,400

-

10.0

6.0

Masarone M et al. [43]

2020

458

2018–2019

12.7

10.0

Fiore V et al. [44]

2021

2,376

2019

10.4

4.3

 Spain

Marco, A et al. [45]

2014

2,377

1992–2011

-

4.9

Cuadrado A et al. [46]

2018

847

2016–2017

13.0

10.2

Jiménez Galan G et al. [47]

2019

1,200

2015

12.4

-

Cabezas J et al. [48]

2021

548

2019–2021

8.0

2.9

 United Kingdom

Taylor A et al. [49]

2013

4,904

2010–2011

19.0

-

Aisyah D et al. [50]

2018

511

2011–2013

4.0

3.1

Morey S et al. [51]

2019

1,495

2016–2017

6.4

3.1

Perrett S et al. [52]

2019

256

2016

3.1

-

Bhandari R et al. [53]

2020

8,538

2016–2020

7.2

4.4

Mohamed Z et al. [54]

2020

2,442

2017–2019

3.7

2.6

Perrett S et al. [55]

2020

6,949

2015–2017

11.0

-

Gahrton C et al. [56]

2019

471

2017

17.0

11.5

 Switzerland

Chacowry P et al. [57]

2018

273

2011–2013

6.2

-

Northern America

 Canada

Courtemanche Y et al. [58]

2018

1,315

2014–2015

12.9

-

 United States

Alvarez KJ et al. [59]

2013

2,788

2009–2013

-

10.1

Cocoros N et al. [60]

2014

596

2009–2011

20.5

-

Wenger PJ et al. [61]

2014

304

2012–2013

16.4

-

Kuncio D et al. [62]

2015

51,562

2011–2012

3.0

-

Beckwith C et al. [63]

2016

249

2012–2014

9.2

6.0

Mahowald M et al. [64]

2016

101,727

2004–2012

18.7

5.2

Schoenbachler B et al. [65]

2016

893

2012–2014

13.2

7.4

Stockman LJ et al. [66]

2016

1,239

2014–2015

12.5

8.9

Akiyama M et al. [67]

2017

10,856

2013–2014

20.6

-

de la Flor C et al. [68]

2017

3042

2015–2016

16.4

-

Hochstatter K et al. [69]

2017

22,918

2015

-

13.6

Assoumou SA et al. [70]

2019

24,567

2012–2016

20.0

7.0

Abe C et al. [71]

2020

4,089

2017

17.3

10.1

Chan J et al. [72]

2020

40,219

2014–2017

-

11.6

Qureshi N et al. [73]

2021

80,681

2000–2019

34.6

-

Latin America

 

 Argentina

Adaszko D et al. [74]

2018

2,181

2015–2017

3.3

-

Mendizabal M et al. [75]

2020

1,141

2018–2020

-

1.1

 Brazil

Barros LA et al. [76]

2013

148

2007–2008

6.1

3.4

Falquetto T et al. [77]

2013

730

2010

1.0

0.8

El Maerrawi I et al. [78]

2015

680

2007

5.3

-

Puga M et al. [79]

2017

3,368

2013–2014

2.4

1.5

Felisberto M et al. [80]

2019

147

2015

5.4

-

Machado F et al. [81]

2019

349

2016–2017

-

8.3

Do Nascimento CT et al. [82]

2020

37,497

2017–2018

-

0.2

 Mexico

Bautista-Arredondo S et al. [83]

2015

17,296

2010

3.2

-

Belaunzaran-Zamudio P et al. [84]

2017

3,192

2011–2012

4.8

-

Silverman-Retana O et al. [85]

2017

391

2010–2011

3.3

-

Central Asia

 Kyrgyzstan

Azbel L et al. [86]

2016

368

2014

42.4

-

East Asia

 Taiwan

Yang TH et al. [87]

2020

824

2019

33.5

23.2

South Asia

 India

Ramamoorthy M et al. [88]

2016

1,381

2015

1.2

-

Tyagi SK et al. [89]

2018

1,611

2016

10.4

-

 Indonesia

Prasetyo AA et al. [90]

2013

375

2009

34.1

 

 Pakistan

Pervaiz A et al. [91]

2015

5,894

2007–2009

-

14.6

Wali A et al. [92]

2019

346

2017

10.4

-

 Sri Lanka

Niriella MA et al. [93]

2015

393

-

6.9

0.5

West Asia

 Iran

Salem F et al. [94]

2013

3,000

2008–2009

0.7

-

Ziaee M et al. [95]

2014

881

2009–2010

-

7.7

Khajedaluee M et al. [96]

2016

1,114

2008

24.5

19.1

Moradi G et al. [97]

2018

6,200

2015

9.5

 

Ghafari S et al. [98]

2019

300

2016

8.0

-

Khademi N et al. [99]

2019

1,034

-

22.2

-

Moradi G et al. [100]

2019

6,481

2016

8.2

-

Sharafi H et al. [101]

2019

1,788

2017–2018

5.9

-

Hariri S et al. [102]

2020

3,485

2017–2018

5.2

3.4

Hariri S et al. [103]

2020

1,892

2018

6.9

4.8

Australasia

 Australia

Reekie JM et al. [104]

2014

1,393

2004–2007-2010

29.8

-

Cunningham E et al. [105]

2017

320

2005–2014

29.1

-

Snow K et al. [106]

2017

1,315

2008–2010

33.8

-

Hajarizadeh B et al. [107]

2021

3?691

2018

-

19.0

Sullivan RP et al. [108]

2021

12,153

2003–2017

4.7

-

West Africa

 Senegal

Jaquet A et al. [109]

2016

333

2014

0.6

-

 Togo

Jaquet A et al. [109]

2016

347

2013

0.3

-

 Nigeria

Okafor IM et al. [110]

2020

142

2018

29.6

-

Sub Saharan Africa

 Ethiopia

Wakjira K et al. [111]

2017

156

2016

2.6

-

Kassa Y et al. [112]

2021

339

2020

1.2

-

Middle East and North Africa

 Egypt

Mohamed HI et al. [113]

2013

500

-

15.8

12.2

  1. Prevalence HCV RNA is the prevalence relative to the total sample size
  2. Abbreviations: HCV hepatitis c virus, Ab antibody